Table 1.

Demographic & clinical characteristics

Demographic characteristics	Value
Median (IQR) Age (years)	60 (51–64)
% Gender (F:M)	4:1 (79% females, 21% males)
% Ethnicity	Caucasian: 57%,
	Pacific Island 14%,
	Maori: 14%,
	Asian: 11%,
	Non-European Caucasian: 4%
Median (IQR) disease duration (years)	15 (7.3–25)
Working: (%)	34%
Not working/Beneficiary: (%)	15%
Retired: (%)	31%
Housewife/homemaker: (%)	15%
Clinical characteristics
Median (IQR) HAQ Score (0–3)	0.9 (0.4, 1.3)
% radiographic erosions	Yes: 67%; No: 33%
Pharmacological management
NSAIDS: n (%)	62 (64%)
Methotrexate: n (%)	65 (67%)
Other DMARDS: n (%)	41 (42%)
Prednisone: n (%)	32 (33%)
Biologics: n (%)	17 (17%)
Blood investigations
Median (IQR) ESR (mg/hr)	27.0 (12.0; 42.3)
Median (IQR) CRP (mm/L)	7.9 (3.8; 7.3)